BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19901975)

  • 1. Ghostwriting: the dirty little secret of medical publishing that just got bigger.
    PLoS Medicine Editors
    PLoS Med; 2009 Sep; 6(9):e1000156. PubMed ID: 19901975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghostwriting in medical literature.
    Int J Occup Environ Health; 2011; 17(2):168-77. PubMed ID: 21618949
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary: What's wrong with ghostwriting?
    Elliott C; Landa AS
    Bioethics; 2010 Jul; 24(6):284-6. PubMed ID: 20497172
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ghostwriting].
    Haug C
    Tidsskr Nor Laegeforen; 2008 May; 128(9):1039. PubMed ID: 18451881
    [No Abstract]   [Full Text] [Related]  

  • 5. Authorship policy.
    Novack GD
    Am J Ophthalmol; 2009 Jan; 147(1):184; author reply 184-5. PubMed ID: 19100357
    [No Abstract]   [Full Text] [Related]  

  • 6. Profits and plagiarism: the case of medical ghostwriting.
    Anekwe TD
    Bioethics; 2010 Jul; 24(6):267-72. PubMed ID: 19222448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sins of ghostwriting.
    Somberg JC
    Am J Ther; 2008; 15(4):297-8. PubMed ID: 18645328
    [No Abstract]   [Full Text] [Related]  

  • 8. Corporate versus public interests: community responsibility to defend scientific integrity.
    Egilman DS; Druar NM
    Int J Occup Environ Health; 2011; 17(2):181-5. PubMed ID: 21618951
    [No Abstract]   [Full Text] [Related]  

  • 9. How to ensure our readers' trust: the proper attribution of authors and contributors.
    Liesegang TJ; Albert DM; Schachat AP
    Am J Ophthalmol; 2008 Sep; 146(3):337-40. PubMed ID: 18724976
    [No Abstract]   [Full Text] [Related]  

  • 10. Ghostwriting: stringent disclosure policies take aim at authorship abuses.
    Nahai F
    Aesthet Surg J; 2010 Mar; 30(2):265-6. PubMed ID: 20442106
    [No Abstract]   [Full Text] [Related]  

  • 11. [The journals must honestly tell who is doing the job].
    Bergström R
    Lakartidningen; 2008 May 7-13; 105(19):1406-7. PubMed ID: 18574981
    [No Abstract]   [Full Text] [Related]  

  • 12. Ghostwriters in the fray: the implications for science, industry, medical journals, and our patients.
    Salcido R
    Adv Skin Wound Care; 2009 Nov; 22(11):494-6. PubMed ID: 20026926
    [No Abstract]   [Full Text] [Related]  

  • 13. Conflicts of interest, authorship, and disclosures in industry-related scientific publications.
    Kelly AR
    Mayo Clin Proc; 2010 Feb; 85(2):200-1. PubMed ID: 20118402
    [No Abstract]   [Full Text] [Related]  

  • 14. Conflict of Interest and the CREATE-X Trial in the New England Journal of Medicine.
    Ozaki A
    Sci Eng Ethics; 2018 Dec; 24(6):1809-1811. PubMed ID: 28916944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Authorship and responsibility in health sciences research: a review of procedures for fairly allocating authorship in multi-author studies.
    Smith E; Williams-Jones B
    Sci Eng Ethics; 2012 Jun; 18(2):199-212. PubMed ID: 21312000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of ghostwriting spurs calls for transparency.
    Collier R
    CMAJ; 2009 Oct; 181(8):E161-2. PubMed ID: 19770248
    [No Abstract]   [Full Text] [Related]  

  • 17. Conflicts of interest, authorship, and disclosures in industry-related scientific publications.
    Fonseca R; Richardson P; Giralt S; Lonial S; Rajkumar SV; Stewart AK; Bensinger W; Somlo G; Vescio R; Mikhael J; Reeder C; Tiedemann R; Tricot G; Rifkin R; Shaughnessy J; Munshi N; Raje N; Ghobrial I; Laubach J; Schlossman R; Treon S; Mahindra A; Avigan D; Rosenblatt J; Jagannath S; Niesvizky R; Landau H; Chen-Kiang S; Siegel DS; Zimmerman T; Mehta J; Vesole D; Rosen S; Hofmeister C; Lacy M; Dispenzieri A; Borrello I; Hayman SR; Kumar S; Buadi F; Dingli D; Russell S; Melissa Alsina MA; Fernandez H; Roy V; Pereira D; Stadtmauer E; Vij R; Jakubowiak A; Lentzsch S; Song K; Trudel S; Chen C; Reece D; Stewart D; Singhal S; Comenzo R; Gertz MA; Greipp PR; Durie B; Barlogie B; Anderson K; Dalton W; Coleman M; Novis S; Kyle RA
    Mayo Clin Proc; 2010 Feb; 85(2):197-9; author reply 201-4. PubMed ID: 20118399
    [No Abstract]   [Full Text] [Related]  

  • 18. Impugning the integrity of medical science: the adverse effects of industry influence.
    DeAngelis CD; Fontanarosa PB
    JAMA; 2008 Apr; 299(15):1833-5. PubMed ID: 18413880
    [No Abstract]   [Full Text] [Related]  

  • 19. The Disposable Author: How Pharmaceutical Marketing Is Embraced within Medicine's Scholarly Literature.
    Matheson A
    Hastings Cent Rep; 2016 Jul; 46(4):31-7. PubMed ID: 27417868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What should be done to tackle ghostwriting in the medical literature?
    Gøtzsche PC; Kassirer JP; Woolley KL; Wager E; Jacobs A; Gertel A; Hamilton C
    PLoS Med; 2009 Feb; 6(2):e23. PubMed ID: 19192943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.